2023-01-12
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. today officially launched its fully human heavy chain antibody platform, RenNano®. RenNano® is the third member of the RenMiceTM family, joining RenMabTM and RenLite®. Together, Biocytogen’s three RenMiceTM platforms allow for the streamlined discovery and development of fully human monoclonal antibodies, bispecific/multispecific antibodies and...
2023-01-11
2023-01-10
2023-01-09
